Sreeja Karathedath
Vellore, TN, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo.
Journal: Frontiers in pharmacology
Published: March 15, 2023
Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients.
Journal: Scientific reports
Published: May 18, 2020
ATP-binding casette transporter expression in acute myeloid leukemia: association with in vitro cytotoxicity and prognostic markers.
Journal: Pharmacogenomics
Published: January 24, 2017
Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2.
Journal: PloS one
Published: January 13, 2017
Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia.
Journal: Cancer chemotherapy and pharmacology
Published: May 02, 2016
RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia.
Journal: Pharmacogenomics
Published: June 18, 2015
Novel NPM1 mutation in the 3'-untranslated region identified in two patients with acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: September 04, 2013
ABCB6 RNA expression in leukemias--expression is low in acute promyelocytic leukemia and FLT3-ITD-positive acute myeloid leukemia.
Journal: Annals of hematology
Published: April 22, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026